SCHEMBL15615170

SCHEMBL15615170

Cc1c(C(=O)NC2CCN(Cc3ccc(N4CCOCC4)nc3)CC2)cccc1-c1cccnc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 1/20 0.64
▸ HPGDS O60760 1/20 0.47
▸ CXCR4 P61073 1/20 0.44
▸ DRD4 P21917 2/20 0.44
▸ CNR2 P34972 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ CD274 Q9NZQ7 1/20 0.42
▸ SLC6A5 Q9Y345 1/20 0.42
▸ ACKR3 P25106 1/20 0.42
▸ CCR3 P51677 1/20 0.42
▸ FLT3 P36888 2/20 0.42
▸ TYRO3 Q06418 2/20 0.42
▸ MERTK Q12866 2/20 0.42
▸ GAS6 Q14393 2/20 0.42
▸ SIGMAR1 Q99720 1/20 0.42
▸ WNT1 P04628 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ PIK3CA P42336 1/20 0.42
▸ MTOR P42345 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16811937 0.97 SMO (0.64) SMOHPGDSCXCR4DRD4CNR2
SCHEMBL16811878 0.94 SMO (0.72) SMOCXCR4DRD4POLBCD274
SCHEMBL16811913 0.92 SMO (0.66) SMOHPGDSCXCR4DRD4POLB
SCHEMBL16811910 0.91 SMO (0.65) SMOCXCR4DRD4POLBCD274
SCHEMBL16811782 0.91 SMO (0.68) SMOCXCR4DRD4POLBCD274
SCHEMBL15615169 0.91 SMO (0.64) SMOHPGDSCXCR4DRD4CNR2
SCHEMBL16811918 0.91 SMO (0.64) SMOHPGDSCXCR4DRD4POLB
SCHEMBL15615184 0.91 SMO (0.64) SMOHPGDSCXCR4DRD4CNR2
SCHEMBL16811967 0.91 SMO (0.51) SMOHPGDSDRD4CNR2POLB
SCHEMBL15615023 0.91 SMO (0.66) SMOHPGDSCXCR4DRD4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed
WO-2014043608-A2 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF DUKE UNIVERSITY (US) 2014-03-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885HPGDS 229/4885CXCR4 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback